San Francisco startup Bumblebee Spaces can make small apartments livable for remote work by turning studios into offices and storing furniture in the ceiling – see how it works

News, market analysis, investment scam prevention tips and more ✔️ Your source for latest asset management news and information. This magazine is crafted specifically for those who are interested in diving into the global asset management world. Bumblebee 2177 San Francisco. Sankarshan Murthy founded Bumblebee Spaces in 2017, after working as a product manager at Apple and a product technologist at Tesla. He wouldn't have been able to start Bumblebee without spending time at those companies, Murthy told Business Insider.Bumblebee is a way to address the lack of affordable housing and people crowded into small apartment, but it's different from typical solutions. From the beginning, Murthy says, the company was focused on addressing the ballooning cost of space, especially in cities. When people can't afford space or are forced into homes that are too small, especially when that includes working from home during the coronavirus pandemic, it leads to "crappy living situations." Fixing the problem of space would either require building out into new areas, which is "terrible for the environment," or making small spaces more appealing. Murthy and Bumblebee focus on the latter. "I would rather make space for wilderness. If you can have a nice backyard, don't put concrete there!" he said of the backyard office trend that emerged this year.Here's a look at how Bumblebee has improved its product and found a niche during the pandemic.One of the locations with Bumblebee's designs is a condo To keep reading about San Francisco startup Bumblebee Spaces can make small apartments livable for remote work by turning studios into offices and storing furniture in the ceiling – see how it works, Click on the link. Seoul, Korea
http://dlvr.it/RpNJJM

Comments

Popular posts from this blog

AstraZeneca Begins Phase I Trial Of AZD7442 Against COVID-19 – Quick Facts

Coronavirus Hasn't Diminished Tech Stocks' Allure

Henlius Plans to File the NDA of Novel anti-PD-1 mAb HLX10 for the Treatment of MSI-H Solid Tumours, the Phase 2 Clinical Trial has Met the Primary Endpoint